Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhild Wildner

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Annals of the New York Academy of Sciences|February 1, 2005
Long-term follow-up of oral tolerance induction with HLA-peptide B27PD in patients with uveitisStephan R Thurau, Harald Fricke, Christian Burchardi, et al.
Protein Engineering, Design & Selection : PEDS|May 6, 2009
Engineering the glycosaminoglycan-binding affinity, kinetics and oligomerization behavior of RANTES: a tool for generating chemokine-based glycosaminoglycan antagonistsBarbara Brandner, Angelika Rek, Maria Diedrichs-Möhring, et al.
Cells|June 24, 2022
Immunogenicity of Novel AAV Capsids for Retinal Gene TherapyMiranda Gehrke, Maria Diedrichs-Möhring, Jacqueline Bogedein, et al.
Ophthalmology|October 10, 2009
Uveitis in a patient treated with Bacille-Calmette-Guérin: possible antigenic mimicry of mycobacterial and retinal antigensAylin Garip, Maria Diedrichs-Möhring, Stephan R Thurau, et al.
European Journal of Immunology|September 11, 2002
Uveitis in horses induced by interphotoreceptor retinoid-binding protein is similar to the spontaneous diseaseCornelia A Deeg, Stephan R Thurau, Hartmut Gerhards, et al.
Journal of Neuroimmunology|June 1, 2005
The effect of the CC chemokine receptor antagonist Met-RANTES on experimental autoimmune uveitis and oral toleranceMaria Diedrichs-Möhring, Peter J Nelson, Amanda E I Proudfoot, et al.
Molecular Immunology|August 24, 2010
Effector T cells driving monophasic vs. relapsing/remitting experimental autoimmune uveitis show unique pathway signaturesChristine von Toerne, Cornelia Sieg, Ulrike Kaufmann, et al.
The Journal of Biological Chemistry|January 26, 2010
Rationally evolving MCP-1/CCL2 into a decoy protein with potent anti-inflammatory activity in vivoAnna Maria Piccinini, Kerstin Knebl, Angelika Rek, et al.
Journal of Neuroinflammation|February 23, 2018
Intraocular DHODH-inhibitor PP-001 suppresses relapsing experimental uveitis and cytokine production of human lymphocytes, but not of RPE cellsMaria Diedrichs-Möhring, Sandy Niesik, Claudia S Priglinger, et al.
International Immunology|September 8, 2004
The fate of autoreactive, GFP+ T cells in rat models of uveitis analyzed by intravital fluorescence microscopy and FACSStephan R Thurau, Thorsten R Mempel, Alexander Flügel, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Annals of the New York Academy of Sciences|February 1, 2005
Long-term follow-up of oral tolerance induction with HLA-peptide B27PD in patients with uveitisStephan R Thurau, Harald Fricke, Christian Burchardi, et al.
Protein Engineering, Design & Selection : PEDS|May 6, 2009
Engineering the glycosaminoglycan-binding affinity, kinetics and oligomerization behavior of RANTES: a tool for generating chemokine-based glycosaminoglycan antagonistsBarbara Brandner, Angelika Rek, Maria Diedrichs-Möhring, et al.
Cells|June 24, 2022
Immunogenicity of Novel AAV Capsids for Retinal Gene TherapyMiranda Gehrke, Maria Diedrichs-Möhring, Jacqueline Bogedein, et al.
Ophthalmology|October 10, 2009
Uveitis in a patient treated with Bacille-Calmette-Guérin: possible antigenic mimicry of mycobacterial and retinal antigensAylin Garip, Maria Diedrichs-Möhring, Stephan R Thurau, et al.
European Journal of Immunology|September 11, 2002
Uveitis in horses induced by interphotoreceptor retinoid-binding protein is similar to the spontaneous diseaseCornelia A Deeg, Stephan R Thurau, Hartmut Gerhards, et al.
Journal of Neuroimmunology|June 1, 2005
The effect of the CC chemokine receptor antagonist Met-RANTES on experimental autoimmune uveitis and oral toleranceMaria Diedrichs-Möhring, Peter J Nelson, Amanda E I Proudfoot, et al.
Molecular Immunology|August 24, 2010
Effector T cells driving monophasic vs. relapsing/remitting experimental autoimmune uveitis show unique pathway signaturesChristine von Toerne, Cornelia Sieg, Ulrike Kaufmann, et al.
The Journal of Biological Chemistry|January 26, 2010
Rationally evolving MCP-1/CCL2 into a decoy protein with potent anti-inflammatory activity in vivoAnna Maria Piccinini, Kerstin Knebl, Angelika Rek, et al.
Journal of Neuroinflammation|February 23, 2018
Intraocular DHODH-inhibitor PP-001 suppresses relapsing experimental uveitis and cytokine production of human lymphocytes, but not of RPE cellsMaria Diedrichs-Möhring, Sandy Niesik, Claudia S Priglinger, et al.
International Immunology|September 8, 2004
The fate of autoreactive, GFP+ T cells in rat models of uveitis analyzed by intravital fluorescence microscopy and FACSStephan R Thurau, Thorsten R Mempel, Alexander Flügel, et al.
Pageof 7